Abstract
The article by Avunduk and associates (Am J Ophthalmol 136:593–602, 2003) on the use of topical corticosteroid drops (TSD) and nonsteroidal anti-inflammatory drops (NSAID) to treat dry eye patients addressed a common clinical problem and provided a potential alternative to the conventional tear replacement and preservation strategy. The authors concluded that TSD were more effective than NSAID and artificial tear substitute (ATS) in reducing the symptoms, signs, and inflammation of patients with keratoconjunctivitis sicca. We would like to discuss a few issues relating to the design and the conclusions of the study.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call